About factor viii recombinant human antihaemophilic
Recombinant clotting factor VIII
Used for
- Prevention and treatment of bleeding in haemophilia A
- Control of bleeding during surgery in haemophilia A
Usual adult dose
Individualized by weight, bleeding severity, and factor VIII levels; commonly 20–40 IU/kg for minor bleeding.
Usual dose in children
Individualized by weight, bleeding severity, and factor VIII levels; commonly 20–40 IU/kg for minor bleeding.
Common side effects
- Headache
- Fever
- Joint pain
- Allergic reactions
Important warnings
- Inhibitor antibodies may reduce treatment effectiveness.
- Severe allergic reactions can occur.
- Not for von Willebrand disease or haemophilia B.
- Dose and monitoring require specialist oversight.
Pregnancy
Limited human data; use when clearly needed, under specialist guidance.
Breastfeeding
Limited data; treatment may be used if clinically necessary, with medical guidance.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.